Flamingo Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 92 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), EFDA (ET) and ZAMRA (ZM). Its GMP standing is certified by CDSCO (India), EMA and MHRA (UK). Customs aggregates show $59.9M of exports covering 1,907 molecules to 17 destinations in 2025.
| Site | FDA FEI |
|---|---|
| DIST. RAIGAD, India | Not on file |
| Nanded, India | Not on file |
| dc industrial estatepalejbharuch 392 220, India | Not on file |
| Gidc, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DAV (Vietnam) | 61 | None |
| EFDA (ET) | 11 | None |
| ZAMRA (ZM) | 8 | None |
| DIGEMAPS (DO) | 8 | None |
| MINSA (CR) | 4 | None |
| CDSCO (India) | None | 2 |
| EMA | None | 1 |
| MHRA (UK) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $7.4M | 10 |
| 2025 | Not reported | $59.9M | 17 |
| 2024 | Not reported | $51.7M | 25 |
| 2023 | Not reported | $47.9M | 23 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Flamingo Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free